African horse sickness caused by genome reassortment and reversion to virulence of live, attenuated vaccine viruses, South Africa, 2004-2014

Weyer, Camilla Theresa; Grewar, John Duncan; Burger, Phillipa; Rossouw, Esthea; Lourens, Carina W.; Joone, Christopher; le Granje, Misha; Coetzee, Peter; Venter, Estelle Hildegard; Martin, Darren P.; MacLachlan, N.J. (James); Guthrie, Alan John

UPSpace Home
→
Veterinary Science
→
Equine Research Centre
→
Research Articles (Equine Research Centre)
→
View Item

We are excited to announce that the repository will soon undergo an upgrade, featuring a new look and feel along with several enhanced features to improve your experience. Please be on the lookout for further updates and announcements regarding the launch date. We appreciate your support and look forward to unveiling the improved platform soon.

African horse sickness caused by genome reassortment and reversion to virulence of live, attenuated vaccine viruses, South Africa, 2004-2014

Weyer, Camilla Theresa; Grewar, John Duncan; Burger, Phillipa; Rossouw, Esthea; Lourens, Carina W.; Joone, Christopher; le Granje, Misha; Coetzee, Peter; Venter, Estelle Hildegard; Martin, Darren P.; MacLachlan, N.J. (James); Guthrie, Alan John

URI: http://hdl.handle.net/2263/58599

Date: 2016-12

Abstract:

African horse sickness (AHS) is a hemorrhagic viral fever of horses. It is the only equine disease for which the World Organization for Animal Health has introduced specific guidelines for member countries seeking official recognition of disease-free status. Since 1997, South Africa has maintained an AHS controlled area; however, sporadic outbreaks of AHS have occurred in this area. We compared the whole genome sequences of 39 AHS viruses (AHSVs) from field AHS cases to determine the source of 3 such outbreaks. Our analysis confirmed that individual outbreaks were caused by virulent revertants of AHSV type 1 live, attenuated vaccine (LAV) and reassortants with genome segments derived from AHSV types 1, 3, and 4 from a LAV used in South Africa. These findings show that despite effective protection of vaccinated horses, polyvalent LAV may, paradoxically, place susceptible horses at risk for AHS.

Show full item record